Uploaded August 2026 | Updated September 2026, 1 week ago
After Meg’s unexpected follicular lymphoma diagnosis, she shares how her doctor helped her navigate treatment options. Fortunately, Meg’s oncologist, Dr. Tara Graff, presented her with an opportunity to join an outpatient clinical trial utilizing bispecific antibodies—a revolutionary, chemo-free therapy designed to supercharge the body’s own immune system to fight the lymphoma. Though the treatment required rigorous 24/7 monitoring for Cytokine Release Syndrome (CRS)
Thank you to Meg L. and Dr. Tara Graff for joining us for this conversation.
Thank you to Genmab for its support of our patient story. The Patient Story retains full editorial control over all content.
#cancerpatient #cancersurvivor #patientstories #thepatientstory #cancertreatment #cancerprevention #cancersymptoms
The Patient Story:
The Patient Story is led by a dedicated team of medical, editorial, and video experts, committed to authentically portraying the cancer patient experience. Sharing your story holds transformative power, culturally and personally. We handle each narrative with utmost care, compassion, and scientific rigor.
Our editorial process adheres to the highest journalistic standards, ensuring medically researched, vetted, and fact-checked content. Backed by experienced medical professionals, we offer insights into the latest medical advancements.
Beyond patient narratives, we provide comprehensive coverage of cancer news and medical resources. From symptoms to clinical trials, insurance, finances, and support groups, we offer guidance in a humanized manner.
Join Our Community:
Sign up for our FREE website: thepatientstory.com
Facebook: facebook.com/thepatientstory
Instagram: instagram.com/thepatientstory
Twitter: twitter.com/Patient_Story
TikTok: tiktok.com/@patientstory
After Meg’s unexpected follicular lymphoma diagnosis, she shares how her doctor helped her navigate treatment options. Fortunately, Meg’s oncologist, Dr. Tara Graff, presented her with an opportunity to join an outpatient clinical trial utilizing bispecific antibodies—a revolutionary, chemo-free therapy designed to supercharge the body’s own immune system to fight the lymphoma. Though the treatment required rigorous 24/7 monitoring for Cytokine Release Syndrome (CRS)
Thank you to Meg L. and Dr. Tara Graff for joining us for this conversation.
Thank you to Genmab for its support of our patient story. The Patient Story retains full editorial control over all content.
#cancerpatient #cancersurvivor #patientstories #thepatientstory #cancertreatment #cancerprevention #cancersymptoms
The Patient Story:
The Patient Story is led by a dedicated team of medical, editorial, and video experts, committed to authentically portraying the cancer patient experience. Sharing your story holds transformative power, culturally and personally. We handle each narrative with utmost care, compassion, and scientific rigor.
Our editorial process adheres to the highest journalistic standards, ensuring medically researched, vetted, and fact-checked content. Backed by experienced medical professionals, we offer insights into the latest medical advancements.
Beyond patient narratives, we provide comprehensive coverage of cancer news and medical resources. From symptoms to clinical trials, insurance, finances, and support groups, we offer guidance in a humanized manner.
Join Our Community:
Sign up for our FREE website: thepatientstory.com
Facebook: facebook.com/thepatientstory
Instagram: instagram.com/thepatientstory
Twitter: twitter.com/Patient_Story
TikTok: tiktok.com/@patientstory
